| Matthew Hagan, MD | |
|
1855 Madison Ave, Idaho Falls, ID 83404-1212 | |
| (208) 881-5351 | |
| Not Available |
| Full Name | Matthew Hagan |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 12 Years |
| Location | 1855 Madison Ave, Idaho Falls, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477800134 | NPI | - | NPPES |
| Entity Name | Bmh Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255539193 PECOS PAC ID: 8426149758 Enrollment ID: O20071018000897 |
News Archive
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted the study protocol for the company's Phase IIb trial of ORMD-0801, its oral insulin capsule, to the U.S. Food and Drug Administration.
3D Mammography finds significantly more invasive cancers and reduces unnecessary recalls, according to a large, retrospective study published in June 25 issue of the Journal of the American Medical Association.
Recently released figures on child deaths in New South Wales have revealed that the number has dropped overall - down almost 40 per cent in the past decade - this equates to 8.6 lives per 100,000 children and young people saved, however this does not appear to apply to indigenous children.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
› Verified 4 days ago
| Entity Name | Mark E Freeman Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902228737 PECOS PAC ID: 9133351422 Enrollment ID: O20140421001642 |
News Archive
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted the study protocol for the company's Phase IIb trial of ORMD-0801, its oral insulin capsule, to the U.S. Food and Drug Administration.
3D Mammography finds significantly more invasive cancers and reduces unnecessary recalls, according to a large, retrospective study published in June 25 issue of the Journal of the American Medical Association.
Recently released figures on child deaths in New South Wales have revealed that the number has dropped overall - down almost 40 per cent in the past decade - this equates to 8.6 lives per 100,000 children and young people saved, however this does not appear to apply to indigenous children.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Hagan, MD Po Box 3446, Idaho Falls, ID 83403-3446 Ph: (208) 552-8580 | Matthew Hagan, MD 1855 Madison Ave, Idaho Falls, ID 83404-1212 Ph: (208) 881-5351 |
News Archive
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted the study protocol for the company's Phase IIb trial of ORMD-0801, its oral insulin capsule, to the U.S. Food and Drug Administration.
3D Mammography finds significantly more invasive cancers and reduces unnecessary recalls, according to a large, retrospective study published in June 25 issue of the Journal of the American Medical Association.
Recently released figures on child deaths in New South Wales have revealed that the number has dropped overall - down almost 40 per cent in the past decade - this equates to 8.6 lives per 100,000 children and young people saved, however this does not appear to apply to indigenous children.
Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
› Verified 4 days ago
Warren E Albrecht, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 2985 Cortez Ave Ste 200, Idaho Falls, ID 83404 Phone: 208-528-1000 Fax: 208-528-1900 | |
Brad D Smith, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 2805 Valencia Dr, Idaho Falls, ID 83404 Phone: 208-552-3184 Fax: 208-525-6151 | |
Dr. Gregory R. Hodson, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2225 Teton Plz, Ste B, Idaho Falls, ID 83404 Phone: 208-524-4660 Fax: 208-524-4617 | |
Dr. John Garth Oliver Miller, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2327 Coronado St Fl 2, Idaho Falls, ID 83404 Phone: 208-528-1750 | |
Dr. Michael Kirk Moore Jr., M.D., P.C. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2860 Channing Way, Suite 213, Idaho Falls, ID 83404 Phone: 208-552-1406 Fax: 208-552-1416 | |
Bruce James Watkins, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3369 Merlin Dr Ste B, Idaho Falls, ID 83404 Phone: 844-919-4263 Fax: 833-513-0980 | |
Adam Meziani, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3200 Channing Way Ste 206, Idaho Falls, ID 83404 Phone: 208-529-2230 |